Gene Symbol | Gene ID | Gene Info |
---|---|---|
Fosl2
|
ENSMUSG00000029135.9 | fos-like antigen 2 |
Bach2
|
ENSMUSG00000040270.10 | BTB and CNC homology, basic leucine zipper transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_32479919_32480224 | Bach2 | 21434 | 0.217634 | -0.74 | 8.0e-11 | Click! |
chr4_32241670_32241990 | Bach2 | 2753 | 0.270927 | -0.73 | 3.4e-10 | Click! |
chr4_32478108_32478259 | Bach2 | 23322 | 0.213682 | -0.72 | 6.0e-10 | Click! |
chr4_32368449_32368600 | Bach2 | 48911 | 0.159041 | -0.69 | 7.1e-09 | Click! |
chr4_32426893_32427050 | Bach2 | 9536 | 0.269908 | -0.68 | 1.5e-08 | Click! |
chr5_32138921_32139090 | Fosl2 | 2832 | 0.212261 | 0.81 | 4.6e-14 | Click! |
chr5_32138517_32138793 | Fosl2 | 2482 | 0.229506 | 0.77 | 9.0e-12 | Click! |
chr5_32139441_32139638 | Fosl2 | 3366 | 0.194613 | 0.75 | 5.6e-11 | Click! |
chr5_32136297_32136481 | Fosl2 | 216 | 0.915955 | 0.71 | 9.0e-10 | Click! |
chr5_32155495_32155646 | Fosl2 | 9049 | 0.148139 | 0.71 | 1.7e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_47371718_47372034 | 29.20 |
Lgals3 |
lectin, galactose binding, soluble 3 |
1937 |
0.21 |
chr13_53919976_53920436 | 23.58 |
E130119H09Rik |
RIKEN cDNA E130119H09 gene |
4458 |
0.2 |
chr19_21106267_21106665 | 19.62 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
1756 |
0.44 |
chr5_150466046_150466511 | 18.31 |
Fry |
FRY microtubule binding protein |
5632 |
0.12 |
chr5_144317459_144317816 | 18.17 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
28730 |
0.12 |
chr11_100962451_100962646 | 18.09 |
Cavin1 |
caveolae associated 1 |
8003 |
0.13 |
chr2_170209124_170209516 | 18.05 |
Zfp217 |
zinc finger protein 217 |
61217 |
0.12 |
chr9_45042149_45042842 | 17.78 |
Mpzl2 |
myelin protein zero-like 2 |
70 |
0.94 |
chr14_121435868_121436092 | 17.36 |
Gm33299 |
predicted gene, 33299 |
19782 |
0.17 |
chr11_60935403_60935625 | 17.08 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3448 |
0.16 |
chr18_60605971_60606545 | 17.07 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr6_94241302_94241597 | 16.43 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
41576 |
0.18 |
chr12_16841116_16841293 | 16.38 |
Gm36495 |
predicted gene, 36495 |
9677 |
0.14 |
chr18_32153114_32153528 | 16.10 |
Gm26717 |
predicted gene, 26717 |
155 |
0.93 |
chr15_77397970_77398160 | 15.82 |
Apol7a |
apolipoprotein L 7a |
386 |
0.74 |
chr10_111576017_111576246 | 15.77 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
18142 |
0.14 |
chr10_77211333_77211524 | 15.76 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44880 |
0.11 |
chr19_42017957_42018130 | 15.27 |
Ubtd1 |
ubiquitin domain containing 1 |
894 |
0.43 |
chr2_61138998_61139217 | 14.88 |
Gm13581 |
predicted gene 13581 |
85685 |
0.09 |
chr12_79471936_79472087 | 14.80 |
Rad51b |
RAD51 paralog B |
144658 |
0.04 |
chr11_59459005_59459317 | 14.78 |
Snap47 |
synaptosomal-associated protein, 47 |
7975 |
0.1 |
chr11_53308418_53308652 | 14.72 |
Hspa4 |
heat shock protein 4 |
8078 |
0.14 |
chr10_89527130_89527354 | 14.71 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
6343 |
0.22 |
chr1_187910832_187911024 | 14.68 |
Esrrg |
estrogen-related receptor gamma |
86899 |
0.09 |
chr13_20433296_20433507 | 14.66 |
Elmo1 |
engulfment and cell motility 1 |
39325 |
0.14 |
chr4_139179928_139180623 | 14.41 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr2_35267247_35267474 | 14.29 |
Gsn |
gelsolin |
10911 |
0.14 |
chr16_87306949_87307599 | 13.96 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
46911 |
0.15 |
chr1_51509108_51509433 | 13.60 |
Gm17767 |
predicted gene, 17767 |
3059 |
0.24 |
chr9_65541744_65541992 | 13.54 |
Gm17749 |
predicted gene, 17749 |
12062 |
0.13 |
chr3_83828190_83828378 | 13.51 |
Tlr2 |
toll-like receptor 2 |
13483 |
0.17 |
chr14_76817069_76817629 | 13.39 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr1_192061751_192061962 | 13.28 |
Traf5 |
TNF receptor-associated factor 5 |
2694 |
0.19 |
chr15_83474131_83474367 | 13.26 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
9643 |
0.14 |
chr19_38025442_38025647 | 13.26 |
Myof |
myoferlin |
17807 |
0.14 |
chr13_5845211_5845415 | 13.23 |
1700016G22Rik |
RIKEN cDNA 1700016G22 gene |
12248 |
0.16 |
chr14_14353319_14353777 | 13.15 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr12_79561049_79561200 | 13.12 |
Rad51b |
RAD51 paralog B |
233771 |
0.02 |
chr11_102643877_102644083 | 13.05 |
Gm22920 |
predicted gene, 22920 |
15700 |
0.09 |
chr14_34588575_34588814 | 13.02 |
Ldb3 |
LIM domain binding 3 |
12 |
0.96 |
chr17_27083731_27083909 | 12.98 |
Mir7677 |
microRNA 7677 |
7425 |
0.1 |
chr2_30920255_30920436 | 12.91 |
Gm13400 |
predicted gene 13400 |
4012 |
0.15 |
chr11_94346751_94346915 | 12.79 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
4353 |
0.17 |
chr15_79368642_79368839 | 12.78 |
Tmem184b |
transmembrane protein 184b |
1253 |
0.3 |
chr6_99931696_99931882 | 12.67 |
Gm44442 |
predicted gene, 44442 |
240 |
0.93 |
chr18_33292812_33293223 | 12.60 |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
79155 |
0.1 |
chr10_77206640_77207012 | 12.58 |
Col18a1 |
collagen, type XVIII, alpha 1 |
40278 |
0.12 |
chr16_78318022_78318316 | 12.52 |
Cxadr |
coxsackie virus and adenovirus receptor |
7038 |
0.16 |
chr15_34254452_34254678 | 12.48 |
Gm18949 |
predicted gene, 18949 |
15264 |
0.15 |
chr6_87868882_87869197 | 12.35 |
Gm44064 |
predicted gene, 44064 |
17830 |
0.07 |
chr12_102422188_102422387 | 12.32 |
Lgmn |
legumain |
1482 |
0.39 |
chr6_50390261_50390625 | 12.18 |
Osbpl3 |
oxysterol binding protein-like 3 |
6707 |
0.26 |
chr10_26828769_26829098 | 12.06 |
Arhgap18 |
Rho GTPase activating protein 18 |
6331 |
0.25 |
chr15_102016198_102016386 | 11.98 |
Krt8 |
keratin 8 |
11810 |
0.11 |
chr16_32859311_32859478 | 11.93 |
Rubcn |
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein |
8944 |
0.14 |
chr17_47958490_47958685 | 11.92 |
Gm5228 |
predicted gene 5228 |
22497 |
0.12 |
chr7_45680019_45680234 | 11.91 |
Ntn5 |
netrin 5 |
3896 |
0.07 |
chr11_62005569_62005810 | 11.89 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
339 |
0.87 |
chr16_95831584_95831933 | 11.89 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
14012 |
0.17 |
chr11_69443424_69443606 | 11.87 |
Dnah2os |
dynein, axonemal, heavy chain 2, opposite strand |
5033 |
0.1 |
chr11_16800630_16801057 | 11.85 |
Egfros |
epidermal growth factor receptor, opposite strand |
29859 |
0.17 |
chr3_90586966_90587210 | 11.78 |
S100a3 |
S100 calcium binding protein A3 |
136 |
0.89 |
chr10_121904122_121904479 | 11.77 |
Gm48804 |
predicted gene, 48804 |
72242 |
0.09 |
chr14_20973860_20974094 | 11.77 |
Vcl |
vinculin |
44579 |
0.14 |
chr14_32164269_32164594 | 11.71 |
Ncoa4 |
nuclear receptor coactivator 4 |
1158 |
0.33 |
chr9_71663389_71664022 | 11.68 |
Cgnl1 |
cingulin-like 1 |
15355 |
0.21 |
chr8_11273520_11273922 | 11.62 |
Col4a1 |
collagen, type IV, alpha 1 |
5935 |
0.18 |
chr7_75427423_75427605 | 11.55 |
Gm44962 |
predicted gene 44962 |
6379 |
0.19 |
chr6_91488966_91489157 | 11.53 |
Tmem43 |
transmembrane protein 43 |
12461 |
0.1 |
chr6_82052193_82052363 | 11.50 |
Eva1a |
eva-1 homolog A (C. elegans) |
29 |
0.81 |
chr14_65345608_65345793 | 11.47 |
Zfp395 |
zinc finger protein 395 |
12689 |
0.15 |
chr2_59670440_59670670 | 11.46 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
23744 |
0.24 |
chr9_70318732_70318904 | 11.35 |
Mir5626 |
microRNA 5626 |
86935 |
0.07 |
chr15_79684081_79684277 | 11.35 |
Gm49520 |
predicted gene, 49520 |
2857 |
0.11 |
chr4_149820664_149820845 | 11.28 |
Gm47301 |
predicted gene, 47301 |
2990 |
0.14 |
chr6_30344055_30344206 | 11.28 |
Gm25625 |
predicted gene, 25625 |
3336 |
0.18 |
chr11_86380580_86380731 | 11.22 |
Med13 |
mediator complex subunit 13 |
23053 |
0.16 |
chr15_37202053_37202303 | 11.16 |
Gm8664 |
predicted gene 8664 |
19477 |
0.13 |
chr10_80137352_80138523 | 11.13 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
13 |
0.91 |
chr2_11429503_11430010 | 11.12 |
Gm13296 |
predicted gene 13296 |
9532 |
0.12 |
chr2_5286574_5286742 | 11.11 |
Gm13197 |
predicted gene 13197 |
3008 |
0.3 |
chr10_120717159_120717370 | 11.09 |
Gm37505 |
predicted gene, 37505 |
14551 |
0.13 |
chr1_182506640_182506943 | 11.07 |
Capn2 |
calpain 2 |
10733 |
0.14 |
chr1_89015543_89015716 | 10.96 |
1700067G17Rik |
RIKEN cDNA 1700067G17 gene |
484 |
0.81 |
chr19_44708999_44709150 | 10.95 |
Gm26644 |
predicted gene, 26644 |
13614 |
0.15 |
chr12_111353338_111354089 | 10.93 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr6_82863545_82863730 | 10.92 |
2310069B03Rik |
RIKEN cDNA 2310069B03 gene |
18195 |
0.1 |
chr11_95842357_95842751 | 10.90 |
Abi3 |
ABI gene family, member 3 |
78 |
0.54 |
chr2_30270162_30270491 | 10.89 |
Phyhd1 |
phytanoyl-CoA dioxygenase domain containing 1 |
3463 |
0.11 |
chr14_63271515_63271859 | 10.86 |
Gata4 |
GATA binding protein 4 |
5 |
0.98 |
chr5_134946861_134947243 | 10.78 |
Cldn4 |
claudin 4 |
118 |
0.91 |
chr10_80071273_80071522 | 10.77 |
Sbno2 |
strawberry notch 2 |
4003 |
0.11 |
chr5_122511628_122511779 | 10.75 |
Gm22965 |
predicted gene, 22965 |
4914 |
0.11 |
chr2_26593817_26594312 | 10.74 |
Egfl7 |
EGF-like domain 7 |
1917 |
0.15 |
chr4_130173547_130173713 | 10.73 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
1061 |
0.47 |
chr5_144321752_144322088 | 10.63 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
33013 |
0.12 |
chr8_33978539_33978943 | 10.59 |
Gm39157 |
predicted gene, 39157 |
7173 |
0.16 |
chr10_20409034_20409406 | 10.56 |
Pde7b |
phosphodiesterase 7B |
37671 |
0.12 |
chr4_132476295_132476463 | 10.54 |
Med18 |
mediator complex subunit 18 |
12458 |
0.1 |
chr18_73830271_73830580 | 10.54 |
Me2 |
malic enzyme 2, NAD(+)-dependent, mitochondrial |
14976 |
0.19 |
chr11_86624366_86624525 | 10.52 |
Gm11478 |
predicted gene 11478 |
6581 |
0.17 |
chr19_24534375_24534662 | 10.51 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
21271 |
0.17 |
chr8_110965696_110965923 | 10.49 |
AC132945.1 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a (Ddx19a), pseudogene |
14338 |
0.1 |
chr5_131814531_131814709 | 10.48 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
65649 |
0.08 |
chr1_181535637_181535820 | 10.46 |
Ccdc121 |
coiled-coil domain containing 121 |
24277 |
0.18 |
chr15_83345013_83345231 | 10.45 |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
5052 |
0.17 |
chr9_96863027_96863187 | 10.43 |
Pxylp1 |
2-phosphoxylose phosphatase 1 |
125 |
0.95 |
chr1_21014556_21014739 | 10.43 |
Tram2 |
translocating chain-associating membrane protein 2 |
29009 |
0.14 |
chr3_81017559_81018001 | 10.40 |
Gm42476 |
predicted gene 42476 |
15174 |
0.15 |
chr4_59239359_59239686 | 10.39 |
Gm12596 |
predicted gene 12596 |
20529 |
0.16 |
chr5_142920749_142921092 | 10.38 |
Actb |
actin, beta |
14166 |
0.14 |
chr9_66876671_66876822 | 10.35 |
Aph1c |
aph1 homolog C, gamma secretase subunit |
42020 |
0.09 |
chr1_153126563_153126733 | 10.34 |
Lamc2 |
laminin, gamma 2 |
267 |
0.92 |
chr5_115235264_115235764 | 10.34 |
Pop5 |
processing of precursor 5, ribonuclease P/MRP family (S. cerevisiae) |
322 |
0.78 |
chr4_150799538_150799727 | 10.33 |
Gm13049 |
predicted gene 13049 |
26101 |
0.15 |
chr5_115493012_115493378 | 10.27 |
Gm13836 |
predicted gene 13836 |
740 |
0.4 |
chr19_32069713_32069864 | 10.27 |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
1044 |
0.64 |
chr6_43292547_43292721 | 10.27 |
Arhgef5 |
Rho guanine nucleotide exchange factor (GEF) 5 |
9752 |
0.12 |
chr1_182528017_182528239 | 10.27 |
Capn2 |
calpain 2 |
10520 |
0.14 |
chr1_93160170_93160488 | 10.26 |
Mab21l4 |
mab-21-like 4 |
541 |
0.68 |
chr4_140665864_140666114 | 10.26 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
23 |
0.97 |
chr2_12325362_12325810 | 10.24 |
Itga8 |
integrin alpha 8 |
23664 |
0.13 |
chr13_5803703_5803929 | 10.20 |
Gm26043 |
predicted gene, 26043 |
18042 |
0.19 |
chr19_32601203_32601359 | 10.20 |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
5491 |
0.24 |
chr11_12394286_12394467 | 10.19 |
Cobl |
cordon-bleu WH2 repeat |
16098 |
0.27 |
chr6_87582644_87582940 | 10.18 |
Prokr1 |
prokineticin receptor 1 |
7927 |
0.14 |
chr2_79566302_79566599 | 10.15 |
Itprid2 |
ITPR interacting domain containing 2 |
68902 |
0.11 |
chr3_135522052_135522278 | 10.14 |
Manba |
mannosidase, beta A, lysosomal |
770 |
0.54 |
chr12_69537409_69537697 | 10.13 |
Gm23018 |
predicted gene, 23018 |
23784 |
0.13 |
chr5_65483956_65484277 | 10.13 |
Gm43290 |
predicted gene 43290 |
6055 |
0.1 |
chr15_59759585_59759917 | 10.13 |
Gm19510 |
predicted gene, 19510 |
35208 |
0.19 |
chr3_115768720_115769146 | 10.10 |
Gm9889 |
predicted gene 9889 |
53783 |
0.11 |
chr2_132613669_132613843 | 10.10 |
AU019990 |
expressed sequence AU019990 |
15561 |
0.14 |
chr1_138929219_138929396 | 10.10 |
Gm3933 |
predicted gene 3933 |
13264 |
0.11 |
chr4_134517051_134517242 | 10.07 |
Aunip |
aurora kinase A and ninein interacting protein |
6147 |
0.11 |
chr4_137367557_137367712 | 10.07 |
Cdc42 |
cell division cycle 42 |
9914 |
0.12 |
chr6_116286832_116287192 | 10.06 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr10_128589582_128590048 | 10.05 |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
163 |
0.86 |
chr11_115869511_115869719 | 10.04 |
Myo15b |
myosin XVB |
7901 |
0.1 |
chr3_83446129_83446447 | 10.03 |
Gm38096 |
predicted gene, 38096 |
42886 |
0.19 |
chr7_128523401_128523909 | 10.03 |
Bag3 |
BCL2-associated athanogene 3 |
39 |
0.96 |
chr1_184781740_184782518 | 10.01 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr1_135183508_135183704 | 9.99 |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
15925 |
0.1 |
chr4_130177155_130177474 | 9.95 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
2192 |
0.26 |
chr15_77836220_77836422 | 9.94 |
Gm22107 |
predicted gene, 22107 |
4435 |
0.17 |
chr6_108442337_108443036 | 9.93 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
16017 |
0.18 |
chr1_39105614_39105791 | 9.91 |
Gm37091 |
predicted gene, 37091 |
22364 |
0.17 |
chr9_106353867_106354018 | 9.91 |
Dusp7 |
dual specificity phosphatase 7 |
14690 |
0.11 |
chr10_128779498_128779802 | 9.89 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr17_17593020_17593172 | 9.83 |
Gm49784 |
predicted gene, 49784 |
1680 |
0.34 |
chr18_36416581_36416796 | 9.81 |
Pfdn1 |
prefoldin 1 |
34556 |
0.13 |
chr9_70889118_70889316 | 9.80 |
Gm3436 |
predicted pseudogene 3436 |
36641 |
0.14 |
chr16_95945355_95946015 | 9.79 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
16608 |
0.16 |
chr5_65457914_65458065 | 9.78 |
Smim14 |
small integral membrane protein 14 |
522 |
0.62 |
chr11_116030063_116031239 | 9.77 |
Unk |
unkempt family zinc finger |
328 |
0.78 |
chr7_135509348_135509534 | 9.76 |
Clrn3 |
clarin 3 |
19213 |
0.15 |
chr19_38470247_38470537 | 9.75 |
Plce1 |
phospholipase C, epsilon 1 |
10717 |
0.22 |
chr12_103737920_103738559 | 9.73 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr4_154269535_154270026 | 9.72 |
Megf6 |
multiple EGF-like-domains 6 |
6 |
0.97 |
chr19_10561676_10561844 | 9.71 |
Tmem216 |
transmembrane protein 216 |
5522 |
0.1 |
chr1_88109131_88109476 | 9.68 |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
2441 |
0.1 |
chr11_5244170_5244566 | 9.65 |
Kremen1 |
kringle containing transmembrane protein 1 |
5920 |
0.18 |
chr5_146691845_146692708 | 9.61 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
14346 |
0.17 |
chr17_70746787_70747024 | 9.61 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
8677 |
0.19 |
chr9_70842516_70842675 | 9.56 |
Gm3436 |
predicted pseudogene 3436 |
9981 |
0.21 |
chr13_35395815_35395979 | 9.56 |
Gm48703 |
predicted gene, 48703 |
514 |
0.84 |
chr9_48707570_48707723 | 9.54 |
Nnmt |
nicotinamide N-methyltransferase |
102493 |
0.06 |
chr7_118930028_118930242 | 9.52 |
Iqck |
IQ motif containing K |
6988 |
0.19 |
chr9_108338578_108339700 | 9.51 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr4_150152597_150152838 | 9.49 |
Slc2a7 |
solute carrier family 2 (facilitated glucose transporter), member 7 |
3745 |
0.15 |
chr5_146779886_146780047 | 9.49 |
Usp12 |
ubiquitin specific peptidase 12 |
15040 |
0.14 |
chr14_25857422_25857620 | 9.44 |
Anxa11os |
annexin A11, opposite strand |
12745 |
0.12 |
chr13_98955412_98955583 | 9.43 |
Gm35215 |
predicted gene, 35215 |
9581 |
0.12 |
chr6_94186528_94186924 | 9.43 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
96299 |
0.08 |
chr11_21402956_21403119 | 9.41 |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
31836 |
0.11 |
chr8_84191995_84192491 | 9.41 |
Gm26887 |
predicted gene, 26887 |
5424 |
0.06 |
chr9_116383500_116383754 | 9.39 |
D730003K21Rik |
RIKEN cDNA D730003K21 gene |
52459 |
0.17 |
chr11_107546171_107546395 | 9.38 |
Helz |
helicase with zinc finger domain |
1647 |
0.25 |
chr11_51916637_51916961 | 9.38 |
Gm39822 |
predicted gene, 39822 |
17833 |
0.14 |
chr2_27858674_27858850 | 9.36 |
Col5a1 |
collagen, type V, alpha 1 |
27663 |
0.18 |
chr9_66988926_66989456 | 9.35 |
Gm24225 |
predicted gene, 24225 |
8006 |
0.16 |
chr16_87348252_87348433 | 9.34 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
5843 |
0.24 |
chr10_121520996_121521267 | 9.34 |
Gm35696 |
predicted gene, 35696 |
10733 |
0.11 |
chr2_84619030_84619389 | 9.33 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
6631 |
0.12 |
chr5_36574661_36574853 | 9.32 |
Tbc1d14 |
TBC1 domain family, member 14 |
432 |
0.8 |
chr7_80401107_80401284 | 9.31 |
Furin |
furin (paired basic amino acid cleaving enzyme) |
512 |
0.64 |
chr13_31567759_31567922 | 9.31 |
Gm11377 |
predicted gene 11377 |
3091 |
0.17 |
chr19_38356392_38356694 | 9.26 |
Gm50150 |
predicted gene, 50150 |
13929 |
0.14 |
chr15_36884759_36884955 | 9.24 |
Gm10384 |
predicted gene 10384 |
5041 |
0.19 |
chr15_73535748_73535932 | 9.23 |
Dennd3 |
DENN/MADD domain containing 3 |
11706 |
0.18 |
chr19_6322376_6322548 | 9.22 |
Cdc42bpg |
CDC42 binding protein kinase gamma (DMPK-like) |
654 |
0.45 |
chr11_119912951_119914125 | 9.22 |
Chmp6 |
charged multivesicular body protein 6 |
97 |
0.95 |
chr1_153129971_153130316 | 9.20 |
Lamc2 |
laminin, gamma 2 |
2909 |
0.26 |
chr5_100608061_100608215 | 9.18 |
Gm43510 |
predicted gene 43510 |
15382 |
0.14 |
chr19_9053077_9053309 | 9.16 |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
34765 |
0.09 |
chr14_70177405_70177952 | 9.15 |
Pdlim2 |
PDZ and LIM domain 2 |
3 |
0.96 |
chr1_91024033_91024229 | 9.15 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
25352 |
0.15 |
chr9_70275267_70275431 | 9.15 |
Myo1e |
myosin IE |
67981 |
0.1 |
chr7_109993498_109993851 | 9.14 |
1600010M07Rik |
RIKEN cDNA 1600010M07 gene |
5559 |
0.1 |
chr13_73803834_73804271 | 9.12 |
Slc12a7 |
solute carrier family 12, member 7 |
557 |
0.73 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 22.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.7 | 14.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
4.6 | 13.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.4 | 13.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
4.3 | 12.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
4.2 | 12.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.1 | 12.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
3.4 | 10.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.4 | 3.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
3.3 | 13.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.2 | 9.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.9 | 11.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
2.8 | 11.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.6 | 2.6 | GO:0045472 | response to ether(GO:0045472) |
2.6 | 7.7 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.5 | 7.6 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.5 | 5.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.5 | 7.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.4 | 4.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.3 | 6.8 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
2.2 | 11.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.2 | 8.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.2 | 6.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.2 | 6.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.2 | 4.4 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.2 | 2.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.1 | 6.4 | GO:1902896 | terminal web assembly(GO:1902896) |
2.1 | 6.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.1 | 6.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.1 | 6.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
2.1 | 6.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.0 | 4.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.0 | 7.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.0 | 7.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.9 | 7.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 17.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.9 | 3.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.9 | 5.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 9.4 | GO:0009249 | protein lipoylation(GO:0009249) |
1.9 | 1.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.8 | 5.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.8 | 7.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.8 | 9.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.8 | 1.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.8 | 5.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.8 | 23.2 | GO:0097320 | membrane tubulation(GO:0097320) |
1.8 | 5.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.7 | 10.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.7 | 8.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.7 | 6.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.7 | 6.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.7 | 5.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 8.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.7 | 5.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.7 | 1.7 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
1.7 | 14.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.6 | 3.2 | GO:0003032 | detection of oxygen(GO:0003032) |
1.6 | 6.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.6 | 6.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.5 | 7.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.5 | 1.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.5 | 6.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.5 | 10.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.5 | 4.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.5 | 4.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.5 | 7.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.5 | 4.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.5 | 4.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.5 | 7.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.5 | 8.8 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.5 | 11.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.4 | 10.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.4 | 5.7 | GO:0015793 | glycerol transport(GO:0015793) |
1.4 | 15.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
1.4 | 8.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.4 | 12.7 | GO:0051014 | actin filament severing(GO:0051014) |
1.4 | 9.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.4 | 4.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.4 | 7.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
1.4 | 4.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.4 | 1.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.4 | 6.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.4 | 5.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.4 | 4.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.4 | 1.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.4 | 5.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.4 | 4.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.4 | 4.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.3 | 5.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.3 | 2.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.3 | 2.6 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
1.3 | 3.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.3 | 1.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.3 | 15.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.3 | 2.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.3 | 3.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.3 | 3.9 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 3.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.3 | 1.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.3 | 3.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.3 | 5.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.2 | 2.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.2 | 3.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 1.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.2 | 2.4 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
1.2 | 7.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.2 | 10.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.2 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.2 | 4.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.2 | 10.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.2 | 2.4 | GO:0035564 | regulation of kidney size(GO:0035564) |
1.2 | 10.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 3.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.2 | 3.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 1.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.2 | 2.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 19.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.1 | 2.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 2.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.1 | 16.0 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.1 | 2.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.1 | 3.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.1 | 3.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.1 | 4.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.1 | 2.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.1 | 2.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.1 | 1.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.1 | 7.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.1 | 2.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.1 | 3.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.1 | 4.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.1 | 3.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.1 | 2.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.1 | 10.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.1 | 4.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.1 | 7.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 12.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.1 | 4.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 4.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.1 | 3.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.1 | 9.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 2.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 3.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.0 | 6.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.0 | 3.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.0 | 10.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.0 | 2.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.0 | 2.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 5.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.0 | 2.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 7.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.0 | 3.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.0 | 11.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.0 | 1.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.0 | 7.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.0 | 4.0 | GO:0018214 | protein carboxylation(GO:0018214) |
1.0 | 4.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.0 | 2.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.0 | 4.9 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.0 | 1.0 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.0 | 2.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.0 | 1.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.0 | 3.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.0 | 1.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.0 | 5.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 9.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.0 | 4.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.9 | 2.8 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 2.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 1.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 1.9 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.9 | 3.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 1.9 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.9 | 4.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 15.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.9 | 0.9 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.9 | 2.7 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.9 | 2.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.9 | 0.9 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.9 | 1.8 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.9 | 3.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.9 | 2.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.9 | 3.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.9 | 0.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.9 | 3.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 0.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.9 | 1.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.9 | 4.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 5.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.9 | 1.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.9 | 2.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.9 | 1.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 1.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 1.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.9 | 14.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.9 | 2.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 8.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.9 | 7.8 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.9 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.9 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 3.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 2.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 0.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.8 | 0.8 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.8 | 5.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.8 | 3.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 0.8 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.8 | 9.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.8 | 3.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 10.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.8 | 4.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 3.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.8 | 2.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.8 | 2.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 1.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.8 | 4.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.8 | 1.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 2.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 5.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.8 | 0.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.8 | 0.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.8 | 4.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 7.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.8 | 3.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.8 | 1.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.8 | 2.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.8 | 5.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.8 | 3.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.8 | 1.6 | GO:0048143 | astrocyte activation(GO:0048143) |
0.8 | 3.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 8.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.8 | 2.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 3.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.8 | 2.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.8 | 2.3 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 1.5 | GO:0007494 | midgut development(GO:0007494) |
0.8 | 1.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 3.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.8 | 1.5 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.8 | 4.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.7 | 18.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 2.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.7 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.7 | 2.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 2.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 3.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 2.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.7 | 5.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 5.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.7 | 2.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 5.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.7 | 2.2 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 2.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.7 | 2.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 0.7 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.7 | 2.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.7 | 2.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.7 | 2.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 2.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 1.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 2.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.7 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 3.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 1.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.7 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 0.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.7 | 3.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.7 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.7 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 0.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.7 | 2.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.7 | 7.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 7.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.7 | 2.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.7 | 3.5 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.7 | 1.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 0.7 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.7 | 1.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 4.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.7 | 1.4 | GO:0009838 | abscission(GO:0009838) |
0.7 | 1.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.7 | 6.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 5.5 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.7 | 4.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 2.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.7 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 2.0 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 3.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 2.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.7 | 4.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 0.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.7 | 3.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.7 | 2.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.7 | 5.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 2.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 2.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.7 | 3.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.7 | 0.7 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.7 | 3.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 3.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.7 | 2.0 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 9.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 1.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.6 | 1.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 3.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 3.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 1.3 | GO:0071872 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
0.6 | 3.8 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.6 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 3.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.6 | 29.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.6 | 1.9 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 3.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 0.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 2.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 1.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 2.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 2.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.6 | 2.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.6 | 3.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.6 | 1.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 1.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 1.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 5.6 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 3.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 5.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.6 | 1.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 3.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.6 | 1.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.6 | 2.5 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.6 | 3.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 2.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 3.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 1.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 0.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.6 | 3.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.6 | 12.1 | GO:0014823 | response to activity(GO:0014823) |
0.6 | 3.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.6 | 3.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 4.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 1.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.6 | 0.6 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.6 | 1.2 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.6 | 3.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.6 | 1.8 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.6 | 1.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.6 | 3.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 1.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 2.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.6 | 1.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 2.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 0.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.6 | 2.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 2.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 2.9 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.2 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.6 | 1.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 1.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.6 | 2.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 4.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 1.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.6 | 2.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 1.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 1.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 2.9 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.6 | 2.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 2.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 2.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 0.6 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.6 | 1.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 2.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.6 | 1.1 | GO:0060068 | vagina development(GO:0060068) |
0.6 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 4.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 18.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 3.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.6 | 2.2 | GO:0042637 | catagen(GO:0042637) |
0.6 | 3.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 6.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.5 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.5 | 4.9 | GO:0034030 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.5 | 1.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 0.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.5 | 0.5 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.5 | 1.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.5 | 1.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 2.2 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.5 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 2.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 4.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 0.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.5 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.5 | 13.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.5 | 1.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.5 | 0.5 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.5 | 2.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.5 | 1.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.5 | 1.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 3.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 1.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.5 | 1.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.5 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 0.5 | GO:0070375 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
0.5 | 3.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.5 | 2.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 1.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.5 | 2.6 | GO:0097531 | mast cell migration(GO:0097531) |
0.5 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 0.5 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.5 | 1.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.5 | 2.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 1.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.5 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.1 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.5 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.5 | 3.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.5 | 2.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 4.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 2.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.5 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 1.0 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 0.5 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.5 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 0.5 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.5 | 2.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 1.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.5 | 0.5 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.5 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 1.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.5 | 3.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 2.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 1.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 1.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 7.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 3.8 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.5 | 2.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 8.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.5 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.5 | 0.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 11.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 9.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 0.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 11.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.5 | 2.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 0.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.5 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 6.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 7.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.5 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 1.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 2.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 1.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.5 | 3.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.5 | 2.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.5 | 1.4 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.5 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 0.5 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.5 | 1.4 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 5.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.5 | 0.9 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 0.9 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.5 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 3.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 0.9 | GO:0035360 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 0.5 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.5 | 0.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.5 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 0.9 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 6.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 8.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 1.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 1.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.4 | 2.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.4 | 4.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.4 | 2.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 3.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 4.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.9 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 1.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 1.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 0.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 1.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 2.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 2.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.4 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.4 | 0.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 4.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 2.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.4 | 4.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.4 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 1.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.4 | 3.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 3.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 3.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 0.4 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 2.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 0.4 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.4 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 1.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 2.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 5.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 0.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 0.8 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 3.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 4.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.4 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.4 | 14.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.4 | 2.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 1.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 3.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.4 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 0.8 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.4 | 2.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 1.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 0.4 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.4 | 2.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 1.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 1.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 4.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 1.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 3.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 3.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 7.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 1.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 1.6 | GO:0046959 | habituation(GO:0046959) |
0.4 | 0.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 8.3 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 0.4 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.4 | 0.8 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 1.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 11.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.4 | 3.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 3.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.9 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.4 | 2.3 | GO:0071046 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.4 | 1.9 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 3.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 0.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 2.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 0.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 3.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 2.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 2.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 1.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 1.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.4 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 3.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.4 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.8 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 0.4 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.4 | 2.3 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.4 | 0.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 0.8 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.4 | 6.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.4 | 0.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 3.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 3.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 7.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 3.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.4 | 5.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 0.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.4 | 7.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.4 | 3.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 14.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.4 | 1.1 | GO:0044851 | hair cycle phase(GO:0044851) |
0.4 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 1.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 1.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 0.7 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.4 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 2.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.4 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 2.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 1.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 2.5 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.4 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 1.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 3.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.7 | GO:0032898 | neurotrophin production(GO:0032898) |
0.4 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 3.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 2.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 2.1 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 1.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.0 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 2.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.7 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.3 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.3 | 2.1 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.3 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 11.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 2.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 1.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 1.0 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 3.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.7 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.3 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.7 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 2.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 5.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 0.7 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 1.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 4.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 1.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 2.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 10.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 0.3 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.3 | 0.3 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.3 | 1.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 1.3 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 1.2 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 2.5 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 0.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.3 | 1.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 1.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 4.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.3 | 2.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 6.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.3 | 2.4 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.3 | 0.3 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 0.9 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 1.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 5.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 4.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.5 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 1.8 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 2.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 2.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) cytochrome complex assembly(GO:0017004) |
0.3 | 0.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 0.6 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 0.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 2.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.9 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.3 | 2.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 1.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.3 | 5.8 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 3.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 1.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 0.9 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 1.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.3 | 2.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 0.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 1.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.3 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 3.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.3 | 2.0 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 7.2 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.3 | 0.8 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 5.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 1.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.7 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 0.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.3 | 5.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 0.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 2.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 2.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 0.5 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.5 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.3 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 0.3 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 2.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 3.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.3 | 0.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 0.5 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.3 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.5 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.3 | 2.0 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.3 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 2.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 1.2 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.5 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.2 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.2 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.2 | 0.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 3.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.7 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.2 | 2.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 2.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.2 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.7 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.2 | 1.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:1901301 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.7 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 1.6 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 0.7 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.2 | 1.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 2.8 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 1.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 1.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 1.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.2 | 2.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 3.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 4.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 0.7 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.9 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.7 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.2 | 1.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 3.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 10.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.2 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 3.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 1.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 5.0 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:1904478 | regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.6 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 1.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.2 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.8 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 1.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.8 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.2 | 1.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.2 | 1.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.2 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.2 | 3.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 3.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 0.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 6.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.4 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.6 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.2 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.2 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.6 | GO:1990266 | neutrophil migration(GO:1990266) |
0.2 | 1.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 2.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.4 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 2.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.6 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 1.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 2.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.7 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.7 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.2 | 1.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.7 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.4 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.2 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.2 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 1.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.5 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.2 | 0.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 0.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 1.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.3 | GO:0046467 | membrane lipid biosynthetic process(GO:0046467) |
0.2 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.0 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 2.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 0.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 0.5 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.2 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.2 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.2 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.2 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.2 | 0.8 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.3 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 0.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 1.5 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 4.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.9 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.3 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.1 | GO:0043534 | blood vessel endothelial cell migration(GO:0043534) |
0.1 | 1.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 1.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.6 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.1 | 1.1 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.6 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.1 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 1.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 1.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 5.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0045583 | cytotoxic T cell differentiation(GO:0045065) regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 1.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0034756 | iron ion transmembrane transport(GO:0034755) regulation of iron ion transport(GO:0034756) |
0.1 | 0.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.7 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.3 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.1 | 0.4 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 2.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 1.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.3 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.2 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 29.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.7 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 3.7 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 1.7 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 1.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.5 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 1.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.6 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.9 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 1.6 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 3.8 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.7 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.1 | 0.5 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.7 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 1.2 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) |
0.1 | 0.5 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.3 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.1 | 2.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.1 | 0.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 1.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 2.3 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.2 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.4 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.2 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.2 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.6 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.6 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 1.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.3 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 3.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 1.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:1902074 | response to salt(GO:1902074) |
0.1 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 1.4 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.2 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.4 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.1 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.6 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.7 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.2 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.3 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.8 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.1 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.9 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.9 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.6 | GO:0051339 | regulation of lyase activity(GO:0051339) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.6 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 2.9 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 2.3 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.2 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.2 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.1 | 1.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:1904377 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.4 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.2 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
0.0 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 1.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.8 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.0 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 1.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.0 | 0.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.0 | 1.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.6 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.7 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.3 | GO:1904888 | embryonic cranial skeleton morphogenesis(GO:0048701) cranial skeletal system development(GO:1904888) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.0 | GO:0002704 | negative regulation of leukocyte mediated immunity(GO:0002704) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0022403 | cell cycle phase(GO:0022403) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.0 | GO:0009069 | serine family amino acid metabolic process(GO:0009069) |
0.0 | 0.0 | GO:0048793 | pronephros development(GO:0048793) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.7 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.6 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.0 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 1.4 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.0 | 0.0 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0051055 | negative regulation of lipid biosynthetic process(GO:0051055) |
0.0 | 0.0 | GO:0036314 | response to sterol(GO:0036314) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.0 | GO:0090504 | epiboly(GO:0090504) |
0.0 | 0.1 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 16.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.3 | 9.9 | GO:0097413 | Lewy body(GO:0097413) |
3.2 | 6.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.8 | 8.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.6 | 7.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.3 | 16.4 | GO:0030056 | hemidesmosome(GO:0030056) |
2.2 | 4.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.2 | 4.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 6.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.2 | 10.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.1 | 12.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.9 | 7.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.9 | 14.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.9 | 9.3 | GO:0005638 | lamin filament(GO:0005638) |
1.9 | 5.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 13.0 | GO:0005861 | troponin complex(GO:0005861) |
1.6 | 16.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.5 | 3.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 27.0 | GO:0043034 | costamere(GO:0043034) |
1.5 | 1.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.5 | 10.3 | GO:0090543 | Flemming body(GO:0090543) |
1.5 | 1.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.4 | 4.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.3 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.3 | 5.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.3 | 5.1 | GO:0071203 | WASH complex(GO:0071203) |
1.3 | 5.1 | GO:0005916 | fascia adherens(GO:0005916) |
1.3 | 5.1 | GO:0032437 | cuticular plate(GO:0032437) |
1.2 | 3.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.2 | 15.8 | GO:0031528 | microvillus membrane(GO:0031528) |
1.2 | 2.4 | GO:0005914 | spot adherens junction(GO:0005914) |
1.2 | 13.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 3.4 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 5.6 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.1 | 6.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.1 | 18.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 1.1 | GO:0070469 | respiratory chain(GO:0070469) |
1.0 | 10.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.0 | 4.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 4.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.0 | 3.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 3.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.0 | 7.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.0 | 6.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 2.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 1.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.9 | 2.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 5.6 | GO:1990462 | omegasome(GO:1990462) |
0.9 | 6.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 3.6 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 7.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 5.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 4.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 5.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.8 | 5.9 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 3.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 11.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 2.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 21.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.8 | 1.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 31.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.8 | 2.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 7.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 45.6 | GO:0042641 | actomyosin(GO:0042641) |
0.7 | 6.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 2.2 | GO:1990357 | terminal web(GO:1990357) |
0.7 | 2.8 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 7.8 | GO:0031430 | M band(GO:0031430) |
0.7 | 4.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 8.4 | GO:0005605 | basal lamina(GO:0005605) |
0.7 | 2.8 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 14.5 | GO:0008305 | integrin complex(GO:0008305) |
0.7 | 2.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.7 | 12.2 | GO:0005922 | connexon complex(GO:0005922) |
0.7 | 2.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.7 | 2.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 5.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 15.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 7.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 3.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 1.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 0.6 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.6 | 6.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 24.1 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 3.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 14.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 5.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.6 | 7.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 4.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 3.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.6 | 3.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 1.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 2.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 2.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 1.7 | GO:0005767 | secondary lysosome(GO:0005767) |
0.6 | 3.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 1.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.5 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 1.6 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 4.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 3.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 5.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 3.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 3.6 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.5 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 2.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 3.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 20.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 2.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 4.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 5.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.5 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 3.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.5 | 8.2 | GO:0031672 | A band(GO:0031672) |
0.5 | 19.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 7.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 3.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 3.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 1.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.4 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 1.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 9.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 1.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 2.6 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.4 | 3.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 8.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 37.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 1.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 29.9 | GO:0031674 | I band(GO:0031674) |
0.4 | 7.5 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 4.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 1.6 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 4.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 2.4 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 26.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 14.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 5.1 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 2.0 | GO:0005903 | brush border(GO:0005903) |
0.4 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 3.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 0.8 | GO:0005912 | adherens junction(GO:0005912) |
0.4 | 9.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.4 | 1.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 8.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 7.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.4 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 0.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 5.8 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 42.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 21.2 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 1.8 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 11.6 | GO:0005901 | caveola(GO:0005901) |
0.3 | 3.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 19.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 2.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 6.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 2.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 29.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 2.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 8.6 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 4.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 11.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 1.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 2.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 5.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.9 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 65.6 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.3 | 1.5 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.3 | 12.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 7.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 5.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.7 | GO:1904949 | ATPase complex(GO:1904949) |
0.3 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 2.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 0.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 3.6 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.3 | 1.3 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 2.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 3.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 2.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 3.9 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.3 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 1.8 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 3.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 23.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 3.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 11.9 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 11.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.7 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 7.3 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 50.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 60.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 5.2 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 5.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 7.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 9.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 1.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 8.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 2.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 35.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 7.0 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 5.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 1.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 0.4 | GO:0030894 | replisome(GO:0030894) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 3.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 7.5 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.5 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.2 | 7.7 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.2 | 2.0 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 2.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 3.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.9 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.5 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 10.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 11.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 2.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 1.9 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 2.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.6 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 1.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 36.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 25.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 5.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 6.8 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 4.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 4.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 4.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 9.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.9 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 8.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 4.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 78.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 3.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 11.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 18.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 4.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 1.5 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 53.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.8 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 68.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 65.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.0 | GO:0030426 | growth cone(GO:0030426) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 35.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.9 | 11.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
3.4 | 13.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
3.3 | 13.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
3.3 | 9.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
3.2 | 9.7 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.2 | 9.5 | GO:0048030 | disaccharide binding(GO:0048030) |
2.9 | 14.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.8 | 8.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.8 | 11.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.8 | 16.8 | GO:0038132 | neuregulin binding(GO:0038132) |
2.5 | 10.1 | GO:0042731 | PH domain binding(GO:0042731) |
2.5 | 10.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.5 | 7.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.5 | 7.4 | GO:0030172 | troponin C binding(GO:0030172) |
2.3 | 6.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.2 | 15.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.2 | 8.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.2 | 10.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.1 | 6.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.1 | 2.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.0 | 10.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.0 | 14.2 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.0 | 8.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
2.0 | 6.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.0 | 8.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.8 | 7.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.8 | 3.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.7 | 5.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.7 | 10.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.7 | 8.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.7 | 16.9 | GO:0044548 | S100 protein binding(GO:0044548) |
1.6 | 3.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.6 | 8.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.6 | 18.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.6 | 12.5 | GO:0008430 | selenium binding(GO:0008430) |
1.5 | 4.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.5 | 9.3 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.4 | 7.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.4 | 18.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.4 | 4.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.4 | 4.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 1.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.4 | 11.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.4 | 5.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.4 | 6.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.4 | 20.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.3 | 6.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.3 | 3.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 15.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.3 | 3.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 2.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.2 | 5.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.2 | 9.9 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 4.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 3.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.2 | 3.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.2 | 3.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.2 | 3.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.2 | 4.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.1 | 4.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.1 | 6.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.1 | 11.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 4.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.1 | 3.4 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.1 | 4.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 5.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.1 | 4.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 3.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 7.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 4.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 2.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.0 | 5.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 4.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.0 | 7.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 4.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 17.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.0 | 2.0 | GO:0015928 | fucosidase activity(GO:0015928) |
1.0 | 4.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.0 | 7.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.0 | 3.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 5.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.0 | 2.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 11.6 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 7.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.9 | 2.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.9 | 5.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.9 | 2.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.9 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 4.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 4.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 10.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 2.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.9 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 3.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 18.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.8 | 2.5 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.8 | 3.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 5.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 2.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 6.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.8 | 3.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 12.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 2.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.8 | 3.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.8 | 2.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.8 | 3.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.8 | 4.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 0.8 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.8 | 5.5 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 2.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.8 | 3.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.8 | 13.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.8 | 7.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.8 | 6.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 0.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.8 | 12.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 13.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 14.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.7 | 0.7 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.7 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 10.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 5.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.7 | 3.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.7 | 1.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 9.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 7.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 2.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 2.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 3.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.7 | 2.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.7 | 1.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.7 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 16.0 | GO:0043236 | laminin binding(GO:0043236) |
0.7 | 2.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 6.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 2.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 2.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 3.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 12.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.7 | 6.0 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 10.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 1.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 6.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 5.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.7 | 2.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 2.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 1.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 7.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 1.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.6 | 2.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 1.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.6 | 1.9 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 1.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 2.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 1.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 1.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 2.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 11.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.9 | GO:2001070 | starch binding(GO:2001070) |
0.6 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 3.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 2.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 2.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 8.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 2.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 2.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 1.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 1.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 1.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 4.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 1.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 2.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.6 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 9.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 3.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 1.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 4.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.6 | 16.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.6 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 1.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 3.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 3.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 2.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 2.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 5.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 1.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.5 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 2.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 2.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 1.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 3.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 1.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 2.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 2.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 2.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 3.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 1.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 6.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 6.3 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.5 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 12.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 3.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 10.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 3.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 3.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 7.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 14.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 3.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 1.0 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 2.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 9.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 10.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 1.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 3.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 3.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 4.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.5 | 4.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 2.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 1.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 1.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 1.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 2.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 2.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 5.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 1.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 2.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 2.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 1.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 2.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.5 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 7.3 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.5 | 2.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 0.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.5 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 2.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 2.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 9.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 1.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 3.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 3.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 4.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 2.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.4 | 2.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 2.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 5.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 3.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 0.4 | GO:0015927 | trehalase activity(GO:0015927) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 3.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 6.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 1.3 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 4.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 3.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.4 | 9.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 2.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 20.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 5.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 2.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 2.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 8.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 2.8 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 2.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 3.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 1.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.4 | 1.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 2.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 19.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 5.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 2.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 17.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 2.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 6.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 4.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 10.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 2.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 3.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 2.9 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 4.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 3.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 1.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 0.9 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 2.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 2.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 1.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 3.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 6.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.3 | 3.6 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 0.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 28.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 1.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 5.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 3.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 0.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 5.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 31.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.8 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 1.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 2.2 | GO:0015922 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) D-lysine oxidase activity(GO:0043912) |
0.3 | 5.9 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 7.7 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 8.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 3.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 2.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 3.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 3.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 1.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 4.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 0.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 0.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 2.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 3.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 5.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 6.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 2.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 7.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 2.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 5.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 1.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 5.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 4.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 2.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 1.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 5.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 5.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 51.9 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 8.7 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.9 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 2.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 10.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 1.5 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 5.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 5.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.4 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 10.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 3.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 9.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 4.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 6.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 3.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 5.8 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 1.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 65.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 3.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 1.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 7.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 2.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 2.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 2.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 61.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 15.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.5 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 37.0 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.9 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 9.1 | GO:0005253 | anion channel activity(GO:0005253) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 4.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 20.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 3.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.4 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 4.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 11.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 2.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 4.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 3.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 2.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 6.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 3.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 6.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 6.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 2.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.8 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.3 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 1.8 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 2.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.1 | GO:0034814 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 1.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 3.6 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 11.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 11.9 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 1.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 16.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 8.8 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 11.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 4.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 3.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 2.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.3 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0018503 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.5 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.0 | 12.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 31.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.9 | 9.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.6 | 41.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.4 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.3 | 10.5 | ST STAT3 PATHWAY | STAT3 Pathway |
1.2 | 36.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.1 | 3.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.1 | 17.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 31.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.0 | 2.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.0 | 2.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 9.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 7.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.9 | 0.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.9 | 25.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.9 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.9 | 9.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 23.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.8 | 4.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 13.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 17.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.7 | 18.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 4.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 2.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 7.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 11.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 5.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 9.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 25.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 13.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 8.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 17.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 13.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 28.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 14.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.6 | 3.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 11.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 2.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 3.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 6.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 3.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 11.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 5.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 14.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 26.5 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 2.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 2.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 9.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 11.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 6.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 13.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 6.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 13.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 3.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 7.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 16.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 4.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 5.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 5.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 7.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 10.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 14.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 3.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 10.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 1.9 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 8.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 14.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 6.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 7.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 11.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 13.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 14.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 10.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 4.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 16.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 20.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 5.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 1.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 40.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 2.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 4.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 0.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 7.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 3.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 2.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 4.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 6.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 33.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 4.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 29.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 21.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 14.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.5 | 14.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.5 | 20.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.4 | 2.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.4 | 22.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 6.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 23.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.3 | 1.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.2 | 27.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.2 | 12.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.2 | 18.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 10.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.1 | 10.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.1 | 10.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.0 | 11.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.0 | 13.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 10.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 12.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.0 | 9.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 14.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.9 | 11.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.9 | 19.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 42.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 8.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 20.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.8 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.8 | 6.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.8 | 19.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 3.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.8 | 12.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.7 | 6.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 8.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 4.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 21.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 3.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 5.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 5.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 1.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 10.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 6.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 7.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 6.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 1.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 6.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 20.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.6 | 5.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 8.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 12.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 6.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 7.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 24.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 7.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 4.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 6.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 2.5 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.5 | 4.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 5.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 6.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 20.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 8.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 5.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 2.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 4.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 5.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 1.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 6.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 2.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 8.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 1.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 1.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 3.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 2.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 21.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 2.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 4.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 2.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 8.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 2.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 7.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 2.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 4.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 9.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 6.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 12.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 4.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.4 | 6.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 3.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 9.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 1.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 4.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.4 | 2.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 1.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.4 | 6.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 1.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 4.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 6.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 6.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 7.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 3.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 5.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 3.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 4.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 5.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 3.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 5.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 13.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 3.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 8.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 7.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 7.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 1.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 3.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 4.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 5.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 8.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 7.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 8.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 9.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 10.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 4.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 13.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 6.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 17.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 7.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 3.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 6.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.5 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.2 | 2.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 6.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 5.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 14.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 3.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 17.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 2.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 7.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 1.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |